Solvay Pharma to merge with Abbott India in a 3:2 share swap

25 Nov 2010

1

Solvay Pharma India yesterday said that its board has approved a proposal to merge with Abbott India under a 2:3 share swap ratio, after the Solvay Group agreed to sell its global pharmaceutical business to Abbott Laboratories last year.

Solvay Pharma said its shareholders would get 3 shares of Abbott India for every 2 held.

Abbott's three shares were worth Rs4,275 on 23 November closing, while Solvay's 2 shares  were worth Rs5,312.

Abbott Park- , Illinois, based Abbott had acquired the pharmaceutical business of Belgium's Solvay for $6.6 billion in cash in September 2009 to take full control of its joint cholesterol drug venture. (See: Abbott to acquire Belgian drug company Solvay for $6.6 billion)

On completion of its acquisition, Abbott Laboratories had acquired an additional 20 per cent of Solvay India in March 2010 through a mandatory open offer, taking its stake up to nearly 89 per cent. (See: Abbott bids for 20 per cent of Solvay India)

Mumbai-based Solvay Pharma India, with a turnover of Rs74 crore for the quarter ended 30 June, was formed in 2002 as a result of the demerger of the pharma business of Duphar-Interfran Ltd.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more